Literature DB >> 28297028

Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION).

Tzu-Lun Huang1, Yao-Tseng Wen2, Chung-Hsing Chang3, Shu-Wen Chang4, Kuan-Hung Lin5, Rong-Kung Tsai6.   

Abstract

Purpose: We investigated whether methylprednisolone (MP) treatment halting retinal ganglion cell (RGC) death and having anti-inflammatory effect over a narrow therapeutic window affects the integrity of the blood-optic nerve barrier (BOB) in a rat model of ischemic optic neuropathy (rAION).
Methods: The optic nerve (ON) vascular permeability was determined by Evans blue extravasation. Changes in the levels of TNF-α and IL-1β cytokines were analyzed using quantitative RT-PCR (qRT-PCR) from day 1 to day 5 post-rAION. Rats were treated with MP starting on days 0, 1, 2, and 7 post-rAION. The survival and apoptosis of the RGCs were determined by fluoroGold labeling and TUNEL assay, and the visual function was assessed with flash visual-evoked potentials (FVEPs) 4 weeks postinfarct. Inflammation of the ON was detected by immunohistochemical staining of ED1.
Results: Macrophage recruitment in the ON was significantly reduced, which was compatible with the reduction in ON vascular permeability, after MP treatment starting on days 0 and 1 postinsult compared to PBS treatment (both, P < 0.05). There was significant reduction in TNF-α and IL-1β expression in MP-treated rats (all, P < 0.05). The survival number and antiapoptotic effect on RGCs, and the P1-N2 FVEP amplitude significantly improved with MP treatment starting on days 0 and 1 (all, P < 0.05). Conclusions: Early treatment with MP halts RGC death and mitigates macrophage infiltration with decreased expression of proinflammatory cytokines in acute rAION. The very narrow therapeutic window is related to the quick stabilization of the disrupted BOB by early application of MP.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28297028     DOI: 10.1167/iovs.16-21017

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Long term therapeutic effects of icariin-loaded PLGA microspheres in an experimental model of optic nerve ischemia via modulation of CEBP-β/G-CSF/noncanonical NF-κB axis.

Authors:  Tushar Dnyaneshwar Desai; Yao-Tseng Wen; Jayasimha Rayalu Daddam; Felice Cheng; Chia-Ching Chen; Chien-Lin Pan; Keh-Liang Lin; Rong-Kung Tsai
Journal:  Bioeng Transl Med       Date:  2022-01-07

2.  Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury.

Authors:  Kishan Kapupara; Yao-Tseng Wen; Rong-Kung Tsai; Shun-Ping Huang
Journal:  Cell Death Dis       Date:  2017-11-16       Impact factor: 8.469

3.  Pentoxifylline and Methylprednisolone Additively Alleviate Kidney Failure and Prolong Survival of Rats after Renal Warm Ischemia-Reperfusion.

Authors:  Grzegorz Wystrychowski; Wojciech Wystrychowski; Władysław Grzeszczak; Andrzej Więcek; Robert Król; Antoni Wystrychowski
Journal:  Int J Mol Sci       Date:  2018-01-11       Impact factor: 5.923

4.  Algae Oil Treatment Protects Retinal Ganglion Cells (RGCs) via ERK Signaling Pathway in Experimental Optic Nerve Ischemia.

Authors:  Tzu-Lun Huang; Yao-Tseng Wen; Yu-Chieh Ho; Jia-Kang Wang; Kuan-Hung Lin; Rong-Kung Tsai
Journal:  Mar Drugs       Date:  2020-01-27       Impact factor: 5.118

5.  Haematococcus pluvialis-Derived Astaxanthin Is a Potential Neuroprotective Agent against Optic Nerve Ischemia.

Authors:  Wei-Ning Lin; Kishan Kapupara; Yao-Tseng Wen; Yi-Hsun Chen; I-Hong Pan; Rong-Kung Tsai
Journal:  Mar Drugs       Date:  2020-01-28       Impact factor: 5.118

6.  The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury.

Authors:  Yu-Yau Chou; Jia-Ying Chien; Jhih-Wei Ciou; Shun-Ping Huang
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

7.  Treatment Effect of CT-Guided Periradicular Injections in Context of Different Contrast Agent Distribution Patterns.

Authors:  Vera Reuschel; Cordula Scherlach; Christian Pfeifle; Matthias Krause; Manuel Florian Struck; Karl-Titus Hoffmann; Stefan Schob
Journal:  Diagnostics (Basel)       Date:  2022-03-23

8.  Transcriptomic Analysis Reveals That Granulocyte Colony-Stimulating Factor Trigger a Novel Signaling Pathway (TAF9-P53-TRIAP1-CASP3) to Protect Retinal Ganglion Cells after Ischemic Optic Neuropathy.

Authors:  Rong-Kung Tsai; Keh-Liang Lin; Chin-Te Huang; Yao-Tseng Wen
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

9.  Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Louise A Mesentier-Louro; Laurel Stell; Yan Yan; Artis A Montague; Vinicio de Jesus Perez; Yaping Joyce Liao
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.048

10.  Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.

Authors:  Pia M Vidal; Antigona Ulndreaj; Anna Badner; James Hong; Michael G Fehlings
Journal:  J Neuroinflammation       Date:  2018-08-06       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.